Saturday, July 4, 2026
ADVT 
International

Indian-American arrested for threatening US varsity students, profs

Darpan News Desk IANS, 14 Mar, 2023 01:16 PM
  • Indian-American arrested for threatening US varsity students, profs

New York, March 14 (IANS) A former University of Wisconsin-Madison graduate student of Indian-origin was arrested after threatening students and staff at his alma mater with an email saying he planned to hide the flesh of their children in hamburger meat, according to media reports.

Arvin Raj Mathur, 32, of Grass Lake in Jackson County, was arrested on Friday at Detroit Metropolitan Airport and he is being temporarily held without bond, The Detroit News reported.

Mathur is being held temporarily without bond in St. Clair County Jail and awaiting a detention hearing on Tuesday in a federal court in Detroit.

A former graduate student in the Department of Anthropology, Mathur is charged with interstate or foreign threat to injure after authorities say he emailed threats from outside the US to nine Wisconsin residents, according to court records.

After being charged with emailing threats to nine people, he made a brief appearance in federal court on Saturday.

Among those emails were one to an anthropology professor saying that two of the other people he had threatened should "sue me right away," authorities said.

"Otherwise, I will murder their children. Call the police and a lawyer, otherwise, I will kill their children and hide their flesh inside of their burger meat," he added in the email, court records show.

He has also been accused of sending another email to an assistant professor of the college with the subject line, "We are going to kill your daughters." That person told officials that "he found the email disturbing and he was scared for his family's safety," according to court records.

"Mr Mathur is presumed innocent, and we'll await future proceedings to comment further," his defence lawyer, Amanda Bashi, wrote in an email to The Detroit News.

There was no immediate comment from a University of Wisconsin-Madison spokesman on Sunday.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19